Azithromycin Suspension Suppliers & Bulk Manufacturers
Available Forms: Suspension
Available Strengths: 100 mg/5 mL
Reference Brands: Zithromax, Z-Pak(US)
Category:
ENT
Azithromycin suspension is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It effectively treats respiratory, skin, and ear infections. Benefits include rapid bacterial clearance, shorter treatment duration, and reduced resistance risk, supporting effective infection management worldwide.
Azithromycin Suspension is available in Suspension
and strengths such as 100 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Azithromycin Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Azithromycin Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Azithromycin suspension, marketed as Zithromax and generic formulations, is regulated as a prescription medication in the US by the FDA and as a medicinal product in the EU via EMA for bacterial infections. Regulatory approval requires dossiers including clinical efficacy, safety profiles, manufacturing practices, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports rapid approval, safe use, and worldwide availability, helping clinicians effectively treat respiratory, skin, and other bacterial infections globally through high-quality, regionally compliant formulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing